Genmab and ADC Therapeutics have partnered to co-develop a new antibody-drug conjugate (ADC) product conjugate to treat multiple cancer indications. The collaboration will integrate Genmab's high-affinity fully human antibody targeting ...
Tags: Genmab, ADC Partner